Albany Med was the first in the region to offer the latest proactive treatment option for patients with Barrett’s esophagus, a precancerous condition commonly caused by chronic acid reflux disease or GERD. With the use of the BARRX HALO systems, Albany Med treats the condition with ablation therapy—the use of high radiofrequency energy to remove the diseased layer of cells—and potentially eliminate the condition before it has the opportunity to progress to cancer.

Learn more about BARRX HALO ablation systems at Albany Med.